B
Bastiaan R. Bloem
Researcher at Radboud University Nijmegen
Publications - 462
Citations - 32688
Bastiaan R. Bloem is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 82, co-authored 359 publications receiving 26750 citations. Previous affiliations of Bastiaan R. Bloem include University of California, Davis & Leiden University Medical Center.
Papers
More filters
Journal ArticleDOI
Connectedness of healthcare professionals involved in the treatment of patients with Parkinson's disease: a social networks study
Michel Wensing,Martijn van der Eijk,Jan Koetsenruijter,Bastiaan R. Bloem,Marten Munneke,Marjan J. Faber +5 more
TL;DR: The authors' measure of professional connectedness proved to be feasible in a regional disease-specific network of health professionals and describing patterns in the professional contacts showed relevant variation across professionals.
Journal ArticleDOI
Dynamic posturography using a new movable multidirectional platform driven by gravity.
D.A.C.M. Commissaris,P.H.J.A. Nieuwenhuijzen,Sebastiaan Overeem,A. de Vos,Jacques Duysens,Bastiaan R. Bloem +5 more
TL;DR: A new movable platform driven by the force of gravity acting upon the platform and the subject standing on it that provides a useful and versatile tool for dynamic posturography.
Journal ArticleDOI
Recognition and diagnosis of sleep disorders in Parkinson's disease
TL;DR: A practical and easily applicable approach to the diagnostic process as a basis for tailored therapeutic interventions and a structured approach facilitates early detection of sleep disturbances in PD, so treatment can be initiated promptly.
Journal ArticleDOI
The state of telemedicine for persons with Parkinson's disease.
TL;DR: In this paper, the authors highlight recent developments in three promising areas of telemedicine: teleconsultation, telemonitoring, and teletreatment, and illustrate this using Parkinson's disease as a model for other chronic neurological disorders.
Journal ArticleDOI
A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid.
Wieneke J.A. van Geel,W. Farid Abdo,René J. F. Melis,Sonja Williams,Bastiaan R. Bloem,Marcel M. Verbeek +5 more
TL;DR: This assay can be routinely applied for quantification of alpha- Synuclein in cerebrospinal fluid, but not in serum, and this may serve as a possible biomarker for alpha-synucleinopathies such as Parkinson's disease and multiple system atrophy.